Correlation Between Mereo BioPharma and Icosavax
Can any of the company-specific risk be diversified away by investing in both Mereo BioPharma and Icosavax at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mereo BioPharma and Icosavax into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mereo BioPharma Group and Icosavax, you can compare the effects of market volatilities on Mereo BioPharma and Icosavax and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mereo BioPharma with a short position of Icosavax. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mereo BioPharma and Icosavax.
Diversification Opportunities for Mereo BioPharma and Icosavax
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Mereo and Icosavax is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Mereo BioPharma Group and Icosavax in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Icosavax and Mereo BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mereo BioPharma Group are associated (or correlated) with Icosavax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Icosavax has no effect on the direction of Mereo BioPharma i.e., Mereo BioPharma and Icosavax go up and down completely randomly.
Pair Corralation between Mereo BioPharma and Icosavax
If you would invest (100.00) in Icosavax on November 29, 2024 and sell it today you would earn a total of 100.00 from holding Icosavax or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Mereo BioPharma Group vs. Icosavax
Performance |
Timeline |
Mereo BioPharma Group |
Icosavax |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Mereo BioPharma and Icosavax Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Mereo BioPharma and Icosavax
The main advantage of trading using opposite Mereo BioPharma and Icosavax positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mereo BioPharma position performs unexpectedly, Icosavax can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Icosavax will offset losses from the drop in Icosavax's long position.Mereo BioPharma vs. Terns Pharmaceuticals | Mereo BioPharma vs. PDS Biotechnology Corp | Mereo BioPharma vs. Inozyme Pharma | Mereo BioPharma vs. Hookipa Pharma |
Icosavax vs. Terns Pharmaceuticals | Icosavax vs. Amylyx Pharmaceuticals | Icosavax vs. Acumen Pharmaceuticals | Icosavax vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |